Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

AbbVie's new endometriosis drug to cost $10K per year
AbbVie's new endometriosis drug to cost $10K per year
The Food and Drug Administration on Tuesday approved AbbVie's gonadotropin-releasing hormone (GnRH) antagonist elagolix, giving a green light to the first oral treatment for moderate-to-s...
Is this the breakthrough that will soon end diabetes? New implant would tackle cause of the disease
Is this the breakthrough that will soon end diabetes? New implant would tackle cause of the disease
A pouch that’s implanted under the skin has the potential to ‘cure’ diabetes, say researchers.
Adding just two-and-a-half teaspoons of sugar to your tea DAILY increases your risk of Alzheimer's by 54%, study finds
Adding just two-and-a-half teaspoons of sugar to your tea DAILY increases your risk of Alzheimer's by 54%, study finds
Adding less than three teaspoons of sugar to your tea every day increases your risk of Alzheimer's disease, new research suggests.
Cannabis may boost the immune system and fight cancer, scientists claim
Cannabis may boost the immune system and fight cancer, scientists claim
Cannabis can strengthen the immune system and fight cancer, according to research.
FDA approves tafenoquine to prevent malaria relapse
FDA approves tafenoquine to prevent malaria relapse
FDA has issued Priority Review marketing approval single-dose tafenoquine (Krintafel) for relapse prevention of Plasmodium vivax malaria in patients aged >16 years receiving appropriate ...
Patient death prompts FDA hold on Mersana’s lead cancer ADC
Patient death prompts FDA hold on Mersana’s lead cancer ADC
Another antibody-drug conjugate has been stalled by concerns over safety.
Swiss, German drugmakers join U.S. price freeze
Swiss, German drugmakers join U.S. price freeze
ZURICH (Reuters) - European drugmakers Roche, Bayer and Merck KGaA became the latest companies to freeze prices in the United States for the rest of 2018 following criticism by President Donal...
Apollo to buy LifePoint in latest private equity bet on healthcare
Apollo to buy LifePoint in latest private equity bet on healthcare
(Reuters) - Apollo Global Management will buy LifePoint Health in a $5.
FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation
FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation
The U.
Pfizer-Lilly pain drug meets late-stage trial goals
Pfizer-Lilly pain drug meets late-stage trial goals
An experimental osteoarthritis drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of lowering pain in a late stage trial, the companies said on Wednesday, potentially offering a ...
Merck lowers prices of some drugs after Trump calls out industry
Merck lowers prices of some drugs after Trump calls out industry
(Reuters) - Merck & Co on Thursday announced price cuts to some of its medicines, including a 60 percent reduction to a hepatitis C treatment, after U.
Selective neuronal silencing using synthetic botulinum molecules alleviates chronic pain in mice
Selective neuronal silencing using synthetic botulinum molecules alleviates chronic pain in mice
Chronic pain affects more than 25 million Americans and is associated with reduced life span, anxiety, and depression.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand